The recently-enacted “America Invents Act” Legislation is the most comprehensive US patent reform since 1952. The final group of changes, several of which will have significant impacts on UTD researchers, will go into effect March 16, 2013. Patent and commercialization strategies used by UTD inventors and the Office of Technology Commercialization will need to change as a result, and some impacts will become apparent months before the changes formally take effect. If you have, or may develop, inventions that may be commercially valuable, come learn from Dr. Lekha Gopalakrishnan of law firm Winstead PC how these changes may impact you.
Please feel free to bring your lunch. Light snacks and beverages will be provided.
For more information, contact Kim Warren at email@example.com or 972-883-4558.
About Dr. Gopalakrishnan: Dr. Lekha Gopalakrishnan is a shareholder in Winstead's Intellectual Property Practice Group and frequently assists UTD inventors with patent prosecution matters. Her practice focuses on all areas of intellectual property law. Dr. Gopalakrishnan has extensive experience with patent prosecution matters in the chemical and biological arts, as well as rendering opinions regarding patentability, patent infringement and patent validity. Additionally, Dr. Gopalakrishnan has counseled clients in matters relating to trademarks and copyrights, including procurement and enforcement, technology licensing, due diligence and freedom to operate investigations of patent portfolios and litigation matters involving patents, trademarks and copyrights. (http://www.winstead.com/Attorneys/lgopalakrishnan)
About the Office of Technology Commercialization (OTC): The UT Dallas Office of Technology Commercialization, a part of the Office of Research, works with UTD researchers to commercialize university-generated intellectual property through patenting, licensing, and start-up company facilitation. (http://www.utdallas.edu/otc)